Press Releases

PHOENIX, Aug. 5, 2019 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading clinical-stage biotechnology company foc

SAN DIEGO, Aug. 5, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced financial results for the three and six months ended June 30, 201

RALEIGH, N.C. and TAMPA, Fla., Aug. 5, 2019 /PRNewswire/ -- WellCare Health Plans, Inc. (NYSE: WCG) has named Eugenie M. Komives, M.D., FAAFP, chief medical officer for North Carolina. Dr. Komives will oversee the plan's medical strategy and clinical direction of health

NORTH CHICAGO, Ill., Aug. 5, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for elagolix, an investigational, oral gonadotropin-releasing hormone

WASHINGTON, Aug. 5, 2019 /PRNewswire/ -- In a joint announcement today, the leaders of PATH and the Telemedicine and Telehealth Service Provider Summit (SPS) have agreed to have SPS formally incorporated into PATH.  The agreement brings to PATH a highly rated and expanding conference that further advances telehealth partnerships."The Arizona Telemedicin

PALO ALTO, Calif., Aug. 5, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company.Last Thursday, the U.S. announced plans to impose a 10 percent tax on $300 billion

WOBURN, Mass., Aug. 5, 2019 /PRNewswire/ -- Bio2 Technologies, Inc., the developer of Vitrium, a unique proprietary structural and resorbable orthobiomaterial, announced the first implantation of an index patient in its randomized, multi-center, non-inferiority IDE Vitrium Cervical Interbody clinical trial.  Bio2 received FDA approval to conduct the trial afte

SAN DIEGO, Aug. 5, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it will release financial results for the three and six months ended June 30,

SAN CARLOS, Calif., Aug. 5, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced results of a prospective validation stu

REHOVOT, Israel and BRIDGEWATER, N.J., Aug. 5, 2019 /PRNewswire/ -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, today announced that it has submitted a New Drug Application